Showing results (71-80 of 120) with videos related to
Sort By:
Pageof 12
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2026
Gut Microbiome Dysbiosis Promotes Gallstone Formation via Bile Acid Metabolic Disorder: A Multiomics StudyChongfei Huang, Weijun Xiao, Jinyu Zhao, et al.The American Journal of Gastroenterology|October 4, 2024
Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort StudiesNingning Mi, Man Yang, Lina Wei, et al.Annals of Medicine|May 30, 2024
Early prediction of acute gallstone pancreatitis severity: a novel machine learning model based on CT features and open access online prediction platformYuhu Ma, Ping Yue, Jinduo Zhang, et al.BMC Pediatrics|August 6, 2025
Development and validation of a novel public prediction platform for deciduous caries in preschool children: an observational study from Northwest ChinaZhidong Zhang, Zhihao Dou, Xu Zhang, et al.The American Journal of Gastroenterology|July 27, 2021
No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million ParticipantsQiangsheng He, Bin Xia, Wenbo Meng, et al.Endoscopy International Open|February 4, 2020
Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinomaYongjiang Ba, Ping Yue, Joseph W Leung, et al.Gastroenterology|August 14, 2021
Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective CohortsBin Xia, Man Yang, Long H Nguyen, et al.Preventive Medicine|March 28, 2024
Genetic risk, adherence to healthy lifestyle behaviors, and risk of cholelithiasis: A population-based cohort studyNingning Mi, Zixin Liang, Man Yang, et al.Eclinicalmedicine|May 8, 2023
Saline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trialYanyan Lin, Man Yang, Jie Cao, et al.Frontiers in Pharmacology|August 2, 2023
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiotaLiang Tian, Chongfei Huang, Wenkang Fu, et al.Pageof 12